Short description
Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.
Description
Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. The company is advancing its lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG).
The company was founded in 2014 and based in Geneva, Switzerland.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Geneva, Geneve, Switzerland, Europe
Founded on
January 1, 2014
Exited on
December 20, 2021
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Arthur Roach